0000950170-24-046178.txt : 20240419
0000950170-24-046178.hdr.sgml : 20240419
20240419192706
ACCESSION NUMBER: 0000950170-24-046178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240418
FILED AS OF DATE: 20240419
DATE AS OF CHANGE: 20240419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Timothy Eugene
CENTRAL INDEX KEY: 0001707000
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 24859262
MAIL ADDRESS:
STREET 1: 800 BOYLSTON ST., SUITE 3310
STREET 2: PRUDENTIAL TOWER C/O AJU IB INVESTMENT
CITY: BOSTON
STATE: MA
ZIP: 02199
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
ownership.xml
4
X0508
4
2024-04-18
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001707000
Sullivan Timothy Eugene
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
false
true
false
false
Chief Financial Officer
false
Common Stock
2024-04-18
4
G
false
14164
0.00
D
79174
D
Common Stock
2024-04-18
4
G
false
14164
0.00
A
70396
I
Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023)
On April 18, 2024, the reporting person transferred 14,164 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
/s/ David Watson, attorney-in-fact for Timothy Sullivan
2024-04-19